PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
345 hedge funds and large institutions have $7.04B invested in PRA Health Sciences, Inc. in 2019 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 125 increasing their positions, 123 reducing their positions, and 33 closing their positions.
79% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 33
36% more call options, than puts
Call options by funds: $11.2M | Put options by funds: $8.22M
13% more capital invested
Capital invested by funds: $6.24B → $7.04B (+$794M)
5% more funds holding
Funds holding: 329 → 345 (+16)
2% more repeat investments, than reductions
Existing positions increased: 125 | Existing positions reduced: 123
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$125M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$111M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$54.1M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$48.4M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$99.5M |
| 2 |
Millennium Management
New York
|
-$75.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$64.7M |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$49.2M |
| 5 |
Bank of New York Mellon
New York
|
-$41.5M |
PRAH Hedge Fund Activity: Q4 2019 in Review
345 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q4 2019, worth a combined $7.04B — up 13% from $6.24B a quarter earlier.
Buyers outnumbered sellers: 59 funds opened new PRAH positions and 33 closed out — a net gain of 26 holders — while 125 added to existing stakes and 123 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $125M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $99.5M sold.
- 345 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q4 2019, up from 329 in Q3 2019.
- Funds reported $7.04B of PRA Health Sciences, Inc. stock for Q4 2019, up 13% quarter-over-quarter.
- 59 funds opened new PRA Health Sciences, Inc. positions in Q4 2019 and 33 closed out, a net change of +26 holders.
- The largest PRA Health Sciences, Inc. buyer in Q4 2019 was Wellington Management Group, an estimated $125M added.
- The largest PRA Health Sciences, Inc. seller in Q4 2019 was Point72 Asset Management, an estimated $99.5M sold.
Based on aggregated 13F filings for Q4 2019.